New Therapy for Rare Anemia
The FDA recently approved the first-in-class therapy luspatercept for treating anemia in adults with β-thalassemia—a rare inherited blood disorder that reduces hemoglobin production.
The FDA recently approved the first-in-class therapy luspatercept for treating anemia in adults with β-thalassemia—a rare inherited blood disorder that reduces hemoglobin production.
This cohort study assesses associations of paternal use of valproate with neurodevelopmental disorders in children.
This cross-sectional study evaluates US medical school faculty diversity before and after introduction of the Liaison Committee on Medical Education’s diversity standards.
This cohort study evaluates the association between patient age and first seizure length in electroconvulsive therapy.
This cohort study examines the association of the neighborhood environment with the onset and severity of menopause at midlife.
This cross-sectional study assesses the risk of cardiovascular complications in a nationwide cohort of Singaporean adults hospitalized for respiratory syncytial virus, influenza, or COVID-19 during…
This cross-sectional study evaluates whether a large language model (LLM) can use unstructured health record notes to accurately identify adult patients who had past-year residence…
This cohort study assesses whether early-life factors are associated with body mass index (BMI) trajectories in children from the Environmental influences on Child Health Outcomes…
This cohort study evaluates and describes the implementation and initial outcomes of a housing benefit program in Oregon.
This cohort study of children and adolescents aged 9 to 12 years evaluates person-level associations between time spent using social media and depressive symptoms over…
This prespecified analysis of a randomized trial examines profiles, risk, and response to finerenone among patients with hearth failure with improved ejection fraction compared with…